Tuesday, 04 August 2020

Dehaier to supply equipment to Beijing hospitals

06 November 2012 | News | By BioSpectrum Bureau

Dehaier to supply equipment to Beijing hospitals and Beijing Kanglian Medicines

All three projects are expected to be completed within the next twelve months

All three projects are expected to be completed within the next twelve months

Singapore: Dehaier Medical has signed three medical equipment procurement agreements with Beijing's Hospitals 304 and 307, two of China's most well-known first-tier hospitals, and with Beijing Kanglian Medicines for the China Development Bank Rural Medical and Health Construction Project. Dehaier expects to recognize revenue of approximately $890,000 from the three projects, all of which are expected to be completed within the next twelve months.

Supported by Philips Electronics Hong Kong and Johnson & Johnson Medical, both well-known American medical equipment companies, Dehaier won the project bids to provide Philips' Color Doppler Ultrasound Diagnostic Systems, Johnson & Johnson's Ultrasonic Scalpels and Beijing-based Yi An's Medical Ventilators.

"In 2011, Dehaier established an account team focused on state-level and other large-scale procurement projects, to foster and develop business with emerging clients with significant purchasing power. Dehaier believes its commitment to exceeding customer expectations and developing long-term and reliable relationships with leading Chinese hospitals and key international medical device manufacturers have made Dehaier successful in bidding for large projects like these new ones," said Mr Ping Chen, CEO of Dehaier. "The time and resources we have devoted to our key account team have paid off for Dehaier. As China keeps investing in healthcare reform and system improvements, Dehaier will continue to leverage its experience and resources to grow with the industry."

In another development, Dehaier Medical entered into a government procurement contract with XinJiang Province in China. The deal is valued at approximately $1,000,000.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls